Banner
Banner
News

GTCbio is delighted to present the 3rd Allergy, Asthma, & COPD Conference, to be held on January 25-26, 2016 in San Diego, CA. The conference will bring together industry, academia and government experts in the field of allergy, asthma and COPD.

Experts will facilitate discourse on the challenges and opportunities for therapeutic and drug development for allergic diseases for the current and future generations. Topics will range from basic scientific research to biomarkers and clinical development. Novel immune targets, new therapeutic interventions, genetics, epigenetics and biomarkers in allergic diseases will be presented.

Please join us for presentations on the latest research as well as networking sessions to meet and collaborate with fellow researchers. We hope to see you in San Diego!

Conference Dates: January 25-26, 2016

https://www.gtcbio.com/conferences/allergy-asthma-copd-overview

Over the years, GTCbio’s 14th Cytokines & Inflammation Conference has become an established meeting point for academic scientists, industry clinical developers, and government researchers to discuss complementary approaches in the field of cytokine biology. We are excited to announce the 13th annual edition of this meeting, which will take place January 25-26, 2016 in San Diego, CA, so mark your calendars and save the date!

Some focused topics we will discuss include developments in the therapeutic application of cytokines and proposal of new targets, the complex relationship between the immune system and microbes in the homeostasis of mucosal tissues, novel means to modulate immune pathways to promote anti-tumor activity, and many more.

Please join us for not only presentations on the latest research, but networking sessions where you will meet and collaborate with fellow researchers on the future of cytokines research! We hope to see you in San Diego!

https://www.gtcbio.com/conferences/cytokines-inflammation-overview

We invite you to GTCbio's Novel Immunotherapeutics Summit, which takes place on January 25 - 26, 2016 in San Diego, CA. The summit will bring together our usual balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain a fresh perspective on the various topics below.

14th Cytokines & Inflammation
This conference has become an established meeting point for academic scientists, industry clinical developers, and government researchers to discuss complementary approaches in the field of cytokine biology. Some focused topics we will discuss include developments in the therapeutic application of cytokines and proposal of new targets, the complex relationship between the immune system and microbes in the homeostasis of mucosal tissues, novel means to modulate immune pathways to promote anti-tumor activity, and many more.

8th Immunotherapeutics & Immunomonitoring
Leading experts from the scientific and clinical arenas and industry will present novel findings and developments in the constantly-changing area of immunological assays and procedures. They will also discuss recent advances in immunotherapy as they relate to various immunotherapy modalities, specific cancers, cell subsets, animal models, and tumor microenvironment. Potential clinical feasibility and commercial potential of the newest data obtained from leading biomedical research laboratories will also be discussed.

4th Immunogenicity & Immunotoxicity
We will provide guests with a better understanding of the ongoing research for tools to mitigate risks associated with the immunogenicity of therapeutic proteins. Guests will get an up-to-date understanding of the mechanisms and consequences of protein aggregation and insights on how to prosecute state-of-the-art assessment of the clinical immunogenicity of therapeutic proteins.

3rd Allergy, Asthma, & COPD
Our gathering is a forum for researchers in the field to share advances in topics ranging from basic scientific research to biomarkers and clinical development. We will take a look at diseases such as eosinophilic esophagitis and atopic dermatitis, along with disorders involving comorbidities like ACOS. Another area of interest includes biomarkers for understanding phenotypes in allergic diseases. This meeting is the ideal event for networking and discussion on progress towards therapeutic potential in these disease areas.

Conference Dates: January 25 - 26, 2016

https://www.gtcbio.com/conferences/immunotherapeutics-summit-overview

The 8th Ocular Diseases Drug Discovery Conference is taking place on March 21-22, 2016 in San Diego, CA. Novel therapeutics from the nanotechnology scope are on the rise. The progress in drug and gene-loaded particles that adequately pass through the mucus barriers provides better delivery to ocular tissue. Recent developments in gene therapies with sustained release of a protein have shown promising results with lesser side effects in patients.

We are gathering leading scientists, researchers, and experts to discuss and collaborate on combating and curing age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, diabetic macular edema (DME), and other ocular diseases. Other hot topics include PRINT® platform for intraocular prostaglandin formulation, coating technology, anti-angiogenic mechanisms and much more!

https://www.gtcbio.com/conferences/ocular-diseases-drug-discovery-overview

We are excited to announce the Enzymes in Drug Discovery Summit, which will take place February 29 - March 2, 2016 in San Diego, CA.

Enzymes have proven to be an important group of drug targets in diseases, and enzyme inhibitors have been among the most successful of drugs. Join us as we discuss ways to overcome drug resistance to these inhibitors, and discuss breakthroughs in targeting historically undruggable enzymes.

This summit will feature the following four conferences:

11th Protein Kinases in Drug Discovery
I. Novel Approaches in Kinase Targeting
II. New Tools and Technologies in Kinase Drug Discovery
III. Kinome Selectivity and Translation to Clinical Safety
IV. Kinase Evolution & Development of Resistance to Kinase Inhibitors

6th Ubiquitin Research & Drug Discovery

I. Advances in Ubiquitin-like Modifications
II. Ubiquitin Pathways in Neurodegenerative Disorders
III. Ubiquitin Proteasome System & Oncology
IV. Autophagy in Cancer & Metabolic Diseases
V. Epigenetic Novel Drug Targets in the Ubiquitin System
VI. Deubiquitinating Enzymes as Drug Targets

2nd Protease Inhibitors in Drug Discovery

I. Membrane-Associated Systems
II. Medical Chemistry & Drug Design of Protease Inhibitors
III. Non-Active Site Inhibition of Proteases
IV. Protease Inhibitors in Translational Research
- Cardiovascular System
- Infectious Diseases
- Inflammatory Diseases
- Neurodegenerative Diseases
- Musculoskeletal Diseases

Epigenetic Enzymes in Drug Discovery

I. Epigenetic Modification & Transcriptional Regulation
II. Pre-Clinical to Clinical Drug Development
III. Immunotherapy: Conversion of Mechanisms
IV. Translating & Combining Antibodies
V. Novel Therapeutic Targets and Discovery

We encourage you to sign up for a summit pass in order to get the most comprehensive look at research and drug discovery happening in the field. In addition to scientific presentations, dedicated networking sessions will allow you to connect and form new relationships with different people in the field and from both the private and public sector.

We hope to see you there!

Conference Dates: February 29 - March 2, 2016

https://www.gtcbio.com/conferences/enzymes-drug-discovery-summit-overview

More Articles...

Page 7 of 36

7
http://www.timtec.net
http://www.zelinsky.com
Banner
Banner
Banner

Upcoming Events

There are no upcoming events currently scheduled.
View full calendar
FacebookMySpaceTwitterDiggDeliciousStumbleuponGoogle BookmarksRedditNewsvineTechnoratiLinkedinMixxRSS Feed